http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100404-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40c009bb1c4fbbf384557146b8016142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b4d6a1f8c723f8e997b6fad88f15107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d9ce98a75b0cf7faeaf8109e9f79f9f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2002-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e626648290f186032fbf96b57a66ca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_147c3ee8794967ae95e50a8182931da0
publicationDate 2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02100404-A3
titleOfInvention Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
abstract The present invention is concerned with formulations for use in a method of suppressing hot flushes, especially hot flushes in hypo-estrogenic females and androgen-deprived males. More particularly the invention relates to a pharmaceutical formulation for use in a method of suppressing hot flushes, said method comprising the administration of the formulation so as to provide on a daily basis a combination of : a. serotonin re-uptake inhibitor in an amount which is equivalent to less than 100 mg trazodone and b. vitamin B6 component, in an amount effective to to reduce the incidence and/or intensity of hot flushes Another aspect of the invention relates to pharmaceutical formulations comprising a combination of a. serotonin re-uptake inhibitor in an amount which is equivalent to 0.6 to 45 mg, preferably 0.6 to 24 mg trazodone and b. 0.005 to 5 nimoles of vitamin B6 component, and additionally comprising pharmaceutically acceptable excipient.
priorityDate 2001-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4329356-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4698342-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0154681-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2303303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9913884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5691325-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56604142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202

Total number of triples: 35.